Personalis Inc PSNL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders?
-
Are PSNL, MKTX, BZH, HOWL Obtaining Fair Deals for their Shareholders?
-
Personalis Reports Second Quarter Results and Recent Highlights
-
Are BOW, UTZ, PSNL Obtaining Fair Deals for their Shareholders?
-
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—LXP, BLFS, PSNL, and FNWD
-
Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders?
-
Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL
-
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
Trading Information
- Previous Close Price
- $16.28
- Day Range
- $16.07–16.32
- 52-Week Range
- $4.96–18.89
- Bid/Ask
- $16.07 / $16.85
- Shares Outstanding
- 106.80M
- Market Cap
- $1.73B
- Volume/Avg
- 2 / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.66
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 260
- Website
- https://www.personalis.com
Valuation
|
Metric
|
PSNL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 7.31 |
Price/Sales | 22.66 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PSNL
|
|---|---|
Quick Ratio | 4.91 |
Current Ratio | 5.28 |
Interest Coverage | −536.72 |
Quick Ratio
PSNL
Profitability
|
Metric
|
PSNL
|
|---|---|
Return on Assets (Normalized) | −33.45% |
Return on Equity (Normalized) | −44.26% |
Return on Invested Capital (Normalized) | −39.67% |
Return on Assets
PSNL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|W&<znj> | LOCK|^X^ | $241B | |||
| Danaher Corp
DHR
| LOCK|^W^bHrN | LOCK|^tZ | $149B | |||
| Agilent Technologies Inc
A
| LOCK|fMwQ$#w! | LOCK|hp | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|VJtHy%$ | LOCK|hQgb | $43B | |||
| Waters Corp
WAT
| LOCK|>vJy?sc | LOCK|$W% | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|#&yM<cV | LOCK|<>y | $41B | |||
| Illumina Inc
ILMN
| LOCK|?X&^$g | LOCK|l<BP | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|j#@%%SLB | LOCK|hq<z | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|zD%@h%& | LOCK|%@q! | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|sPd@p%@ | LOCK|B$Nh | $25B |
United States